FDA Awards Breakthrough Device Designation to Enspectra Health’s AI Platform for Classifying Non-melanoma Skin Cancers

June 6, 2024

ASCO: Neoadjuvant Immunotherapy Wows in Early Stage Melanoma

June 3, 2024

Almirall Survey: Many People Don’t Know What Causes AK

May 28, 2024

FDA Moves Up PDUFA Date for Subcutaneous Nivolumab

May 22, 2024

Nevisense’s EIS Technology Improves Correct Biopsy Choice for Melanomas, Other Lesions

May 22, 2024

Up to 15% of Melanoma Patients Are Genetically Predisposed to the Cancer

May 21, 2024

Meet the ASA 2024 Research Achievement Award & Inaugural Founders Award Winners

May 20, 2024

Exploring the Role of Microwaves for the Treatment of Non-melanoma Skin Cancers

May 17, 2024

Can Serum SHOX2 Methylation Predict Response to Immunotherapy in Melanoma?

May 16, 2024

CeraVe Expands Sun Safety Day Initiative at Four Ballparks

May 16, 2024

When It Comes to Sun Protection Knowledge, Gen Z Adults Are More Likely to Receive Ds or Fs

May 15, 2024

And the Winner Is … The American Skin Association’s SPOTS Program

May 14, 2024